Comparison of allogeneic stem cell trans
β
Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou;
π
Article
π
2003
π
John Wiley and Sons
π
English
β 148 KB
π 2 views
## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), highβdose cytarabine (araβC; HiDAC), and autologous SCT as